These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27816673)

  • 1. Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).
    Lee YS; Yi JS; Seo SJ; Kim JH; Jung MS; Seo IK; Ahn I; Ko K; Kim TS; Lim KM; Sohn S
    Regul Toxicol Pharmacol; 2017 Feb; 83():13-22. PubMed ID: 27816673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry.
    Han BI; Yi JS; Seo SJ; Kim TS; Ahn I; Ko K; Kim JH; Bae S; Lee JK
    Regul Toxicol Pharmacol; 2019 Oct; 107():104401. PubMed ID: 31158384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.
    Jung KM; Jang WH; Lee YK; Yum YN; Sohn S; Kim BH; Chung JH; Park YH; Lim KM
    Toxicol Lett; 2012 Mar; 209(3):255-63. PubMed ID: 22245253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance standard-based validation study for local lymph node assay: 5-bromo-2-deoxyuridine-flow cytometry method.
    Ahn I; Kim TS; Jung ES; Yi JS; Jang WH; Jung KM; Park M; Jung MS; Jeon EY; Yeo KU; Jo JH; Park JE; Kim CY; Park YC; Seong WK; Lee AY; Chun YJ; Jeong TC; Jeung EB; Lim KM; Bae S; Sohn S; Heo Y
    Regul Toxicol Pharmacol; 2016 Oct; 80():183-94. PubMed ID: 27318101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamasaki K; Kimber I
    J Appl Toxicol; 2006; 26(1):5-9. PubMed ID: 16217858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
    Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
    J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
    Arancioglu S; Ulker OC; Karakaya A
    Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of flow cytometry and immunohistochemistry in non-radioisotopic murine lymph node assay using bromodeoxyuridine.
    Jung KM; Bae IH; Kim BH; Kim WK; Chung JH; Park YH; Lim KM
    Toxicol Lett; 2010 Feb; 192(2):229-37. PubMed ID: 19879932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of within- and between-laboratory reproducibility of non-radioisotopic local lymph node assay using flow cytometry, LLNA:BrdU-FCM: comparison of OECD TG429 performance standard and statistical evaluation.
    Yang H; Na J; Jang WH; Jung MS; Jeon JY; Heo Y; Yeo KW; Jo JH; Lim KM; Bae S
    Toxicol Lett; 2015 May; 234(3):172-9. PubMed ID: 25732604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local lymph node assay: 5-bromo-d-deoxyuridine-ELISA method for comparative study in assessing chemical potencies and skin sensitization in BALB/c and CBA/J strains.
    Oh JJ; Park ES; Kim SS; Lee MS; Lee WJ; Pak BS; Kim MS; Lee HK; Song SW; Kim SD
    Toxicol Rep; 2022; 9():499-504. PubMed ID: 35345861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-laboratory study to determine the reproducibility of LLNA:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Chen W; Xing C; Hou F
    J Pharmacol Toxicol Methods; 2016; 82():26-30. PubMed ID: 27456929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
    Lee JK; Park JH; Park SH; Kim HS; Oh HY
    J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of the proposed GHS subcategorization criterion for LLNA:BrdU-ELISA (OECD TG442B) to the CBA/J strain mouse.
    Kobayashi T; Maeda Y; Kondo H; Takeyoshi M
    J Appl Toxicol; 2020 Oct; 40(10):1435-1439. PubMed ID: 32372462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive capacity of a non-radioisotopic local lymph node assay using flow cytometry, LLNA:BrdU-FCM: Comparison of a cutoff approach and inferential statistics.
    Kim DE; Yang H; Jang WH; Jung KM; Park M; Choi JK; Jung MS; Jeon EY; Heo Y; Yeo KW; Jo JH; Park JE; Sohn SJ; Kim TS; Ahn IY; Jeong TC; Lim KM; Bae S
    J Pharmacol Toxicol Methods; 2016; 78():76-84. PubMed ID: 26654807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporation.
    Kojima H; Takeyoshi M; Sozu T; Awogi T; Arima K; Idehara K; Ikarashi Y; Kanazawa Y; Maki E; Omori T; Yuasa A; Yoshimura I
    J Appl Toxicol; 2011 Jan; 31(1):63-74. PubMed ID: 20677212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison.
    Piccotti JR; Knight SA; Gillhouse K; Lagattuta MS; Bleavins MR
    J Appl Toxicol; 2006; 26(4):333-40. PubMed ID: 16705757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes obtained in murine local lymph node assays using CBA/J or CBA/Ca mice.
    Maeda Y; Hirosaki H; Yakata N; Takeyoshi M
    J Appl Toxicol; 2016 Aug; 36(8):1011-4. PubMed ID: 26456381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4.
    Ha S; Ahn IY; Kim DE; Lee JK; Sohn S; Jung MS; Heo Y; Omori T; Bae S; Lim KM
    Regul Toxicol Pharmacol; 2017 Apr; 85():124-131. PubMed ID: 28193562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.